The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 111K | $76.00 | $8.4M |
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 102K | — | — |
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 225K | — | — |
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 68K | — | — |
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 325K | — | — |
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 173K | — | — |
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 990K | — | — |
| Aug 17, 2022 | Countouriotis Athena | President & CEO, Director | Disposed to issuer(D) | 156K | — | — |
| Aug 17, 2022 | Hirmand Mohammad | EVP and Chief Medical Officer | Disposed to issuer(D) | 41K | $76.00 | $3.1M |
| Aug 17, 2022 | Hirmand Mohammad | EVP and Chief Medical Officer | Disposed to issuer(D) | 169K | — | — |
| Aug 17, 2022 | Hirmand Mohammad | EVP and Chief Medical Officer | Disposed to issuer(D) | 29K | — | — |
| Aug 17, 2022 | Hirmand Mohammad | EVP and Chief Medical Officer | Disposed to issuer(D) | 68K | — | — |
| Aug 17, 2022 | Sabus Steve M | SVP & Chief Commercial Officer | Disposed to issuer(D) | 37K | $76.00 | $2.8M |
| Aug 17, 2022 | Sabus Steve M | SVP & Chief Commercial Officer | Disposed to issuer(D) | 165K | — | — |
| Aug 17, 2022 | Sun Brian | SVP & General Counsel | Disposed to issuer(D) | 45K | $76.00 | $3.4M |
| Aug 17, 2022 | Sun Brian | SVP & General Counsel | Disposed to issuer(D) | 195K | — | — |
| Aug 17, 2022 | Tombesi Paolo | EVP & Chief Financial Officer | Disposed to issuer(D) | 30K | $76.00 | $2.3M |
| Aug 17, 2022 | Tombesi Paolo | EVP & Chief Financial Officer | Disposed to issuer(D) | 61K | — | — |
| Aug 17, 2022 | Tombesi Paolo | EVP & Chief Financial Officer | Disposed to issuer(D) | 59K | — | — |
| Aug 17, 2022 | Alles Mark J | Director | Disposed to issuer(D) | 2K | $76.00 | $152K |
| Aug 17, 2022 | Alles Mark J | Director | Disposed to issuer(D) | 209 | — | — |
| Aug 17, 2022 | Alles Mark J | Director | Disposed to issuer(D) | 17K | — | — |
| Aug 17, 2022 | Bodem Barbara W. | Director | Disposed to issuer(D) | 15K | — | — |
| Aug 17, 2022 | Gallagher Carol Giltner | Director | Disposed to issuer(D) | 9K | — | — |
| Aug 17, 2022 | Gallagher Carol Giltner | Director | Disposed to issuer(D) | 9K | — | — |
| Aug 17, 2022 | Gallagher Carol Giltner | Director | Disposed to issuer(D) | 30K | — | — |
| Aug 17, 2022 | George Simeon | Director | Disposed to issuer(D) | 2.3M | $76.00 | $171.3M |
| Aug 17, 2022 | George Simeon | Director | Disposed to issuer(D) | 15K | — | — |
| Aug 17, 2022 | George Simeon | Director | Disposed to issuer(D) | 9K | — | — |
| Aug 17, 2022 | George Simeon | Director | Disposed to issuer(D) | 9K | — | — |
| Aug 17, 2022 | Machado Patrick | Director | Disposed to issuer(D) | 30K | — | — |
| Aug 17, 2022 | Machado Patrick | Director | Disposed to issuer(D) | 9K | — | — |
| Aug 17, 2022 | Machado Patrick | Director | Disposed to issuer(D) | 9K | — | — |
| Aug 17, 2022 | Nicholson Garry A | Director | Disposed to issuer(D) | 9K | — | — |
| Aug 17, 2022 | Nicholson Garry A | Director | Disposed to issuer(D) | 23K | — | — |
| Jul 27, 2022 | Tombesi Paolo | EVP & Chief Financial Officer | Sell(S) | 1K | $74.94 | $89K |
| May 31, 2022 | Sabus Steve M | SVP & Chief Commercial Officer | Grant(A) | 37K | — | $0 |
| May 31, 2022 | Sabus Steve M | SVP & Chief Commercial Officer | Grant(A) | 165K | — | $0 |
| Apr 11, 2022 | Sun Brian | SVP & General Counsel | Grant(A) | 45K | — | $0 |
| Apr 11, 2022 | Sun Brian | SVP & General Counsel | Grant(A) | 195K | — | $0 |
| Feb 9, 2022 | Tombesi Paolo | EVP & Chief Financial Officer | Grant(A) | 59K | — | $0 |
| Feb 9, 2022 | Tombesi Paolo | EVP & Chief Financial Officer | Grant(A) | 16K | — | $0 |
| Feb 9, 2022 | Reich Siegfried | EVP & Chief Scientific Officer | Grant(A) | 49K | — | $0 |
| Feb 9, 2022 | Reich Siegfried | EVP & Chief Scientific Officer | Grant(A) | 14K | — | $0 |
| Feb 9, 2022 | Reich Siegfried | EVP & Chief Scientific Officer | Sell(S) | 397 | $36.30 | $14K |
| Feb 9, 2022 | Partridge Andrew John | EVP & Chief Commercial Officer | Grant(A) | 59K | — | $0 |
| Feb 9, 2022 | Partridge Andrew John | EVP & Chief Commercial Officer | Grant(A) | 16K | — | $0 |
| Feb 9, 2022 | Partridge Andrew John | EVP & Chief Commercial Officer | Sell(S) | 221 | $36.30 | $8K |
| Feb 9, 2022 | North Annette | EVP & General Counsel | Grant(A) | 59K | — | $0 |
| Feb 9, 2022 | North Annette | EVP & General Counsel | Sell(S) | 669 | $36.30 | $24K |
| Feb 9, 2022 | North Annette | EVP & General Counsel | Grant(A) | 16K | — | $0 |
| Feb 9, 2022 | Hirmand Mohammad | EVP & Chief Medical Officer | Grant(A) | 68K | — | $0 |
| Feb 9, 2022 | Hirmand Mohammad | EVP & Chief Medical Officer | Grant(A) | 19K | — | $0 |
| Feb 9, 2022 | Hirmand Mohammad | EVP & Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Feb 9, 2022 | Hirmand Mohammad | EVP & Chief Medical Officer | Sell(S) | 669 | $36.30 | $24K |
| Feb 9, 2022 | Countouriotis Athena | President & CEO, Director | Grant(A) | 225K | — | $0 |
| Feb 9, 2022 | Countouriotis Athena | President & CEO, Director | Grant(A) | 62K | — | $0 |
| Feb 9, 2022 | Countouriotis Athena | President & CEO, Director | Sell(S) | 3K | $36.30 | $108K |
| Aug 30, 2021 | North Annette | EVP, General Counsel & Secty. | Option exercise(M) | 10K | — | $0 |
| Aug 30, 2021 | North Annette | EVP, General Counsel & Secty. | Sell(S) | 10K | $80.00 | $800K |
| Aug 30, 2021 | North Annette | EVP, General Counsel & Secty. | Option exercise(M) | 10K | $17.00 | $170K |
| Jul 26, 2021 | Tombesi Paolo | EVP & Chief Financial Officer | Grant(A) | 61K | — | $0 |
| Jul 26, 2021 | Tombesi Paolo | EVP & Chief Financial Officer | Grant(A) | 14K | — | $0 |
| Jul 14, 2021 | Partridge Andrew John | EVP & Chief Commercial Officer | Sell(S) | 2K | $74.90 | $140K |
| May 6, 2021 | North Annette | EVP, General Counsel & Secty. | Option exercise(M) | 6K | — | $0 |
| May 6, 2021 | North Annette | EVP, General Counsel & Secty. | Option exercise(M) | 6K | $17.00 | $100K |
| Mar 31, 2021 | Bodem Barbara W. | Director | Grant(A) | 15K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).